hVIVO’s Mo Khan: “We have now got 100% contracted work this year to hit our revenue targets”.
Episode 1556, Jul 26, 2023, 02:55 PM
Mo Khan, chief executive of hVIVO (HVO ), talks to Vox about the company’s latest
trading update, which has seen revenues grow by more than 50% and its order book hit £78m, leaving it on track to hit full year numbers and with significant revenue visibility well into 2024.
0:37 An overview of the first half trading update, which has seen growing
revenue, improving margins, and strong cash generation.
2:22 Explaining the change to exclude R&D tax credits from reported revenues to
improve transparency.
4:04 Discussing the composition of the record £78m order book and how it
provides strong revenue visibility into 2024.
5:45 Why contract sizes are increasing, and how hVIVO has been able to scale up
to deliver.
8:08 How diversification and prudent management has helped offset capacity
issues at the UK’s medicines regulator, the MHRA.
9:47 What to expect throughout the rest of 2023.
trading update, which has seen revenues grow by more than 50% and its order book hit £78m, leaving it on track to hit full year numbers and with significant revenue visibility well into 2024.
0:37 An overview of the first half trading update, which has seen growing
revenue, improving margins, and strong cash generation.
2:22 Explaining the change to exclude R&D tax credits from reported revenues to
improve transparency.
4:04 Discussing the composition of the record £78m order book and how it
provides strong revenue visibility into 2024.
5:45 Why contract sizes are increasing, and how hVIVO has been able to scale up
to deliver.
8:08 How diversification and prudent management has helped offset capacity
issues at the UK’s medicines regulator, the MHRA.
9:47 What to expect throughout the rest of 2023.